Affectis Pharmaceuticals Ag

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 50.0

EPO Patents = 2

Forward Citations = 5

Loading Chart...

5 inventors (with patents filed for the assignee):

Michael Bös (3 out of 3 patents)

Michael C Boes (2 out of 3 patents)

Marcelo Paez-Pereda (1 out of 3 patents)

4. Nicholas Barden (1 out of 1 patent)

5. Inge Sillaber (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 8815892 - P2X7R antagonists and their use (2014-08-26),

2. 8569334 - P2X7R antagonists and their use (2013-10-29),

3. 8268861 - P2X7R antagonists and their use (2012-09-18),

4. 8232290 - P2X7R antagonists and their use (2012-07-31),

5. 7919503 - P2X7R antagonists and their use (2011-04-05),

6. 7767398 - Means and methods for diagnosing and treating affective disorders (2010-08-03),

Company Overview

Affectis Pharmaceuticals Ag is a leading biopharmaceutical company focused on developing innovative treatments for neurological disorders. With a strong pipeline of novel drug candidates targeting serotonin receptors, Affectis aims to address unmet medical needs in depression, anxiety, and other central nervous system disorders. Through strategic partnerships and collaborations, Affectis is dedicated to advancing the science of neuroscience and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#12 in Martinsried

#5,406 in Germany

Martinsried, Germany

Affectis Pharmaceuticals Ag

Forward Citations = 5

5 inventors:

Michael Bös (3 out of 3 patents)

Michael C Boes (2 out of 3 patents)

Marcelo Paez-Pereda (1 out of 3 patents)

4. Nicholas Barden (1 out of 1 patent)

5. Inge Sillaber (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Affectis Pharmaceuticals Ag. Retrieved from https://idiyas.com/company/affectis-pharmaceuticals-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]